Indication
Cord Blood Transplant
3 clinical trials
2 products
Clinical trial
An Open-label, Multi-center, Phase I/II Study of MFA-370 in Patients With Metastatic Urothelial CancerStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
ECT-001-CBClinical trial
A Phase II Open-Label Study of UM171-Expanded Cord Blood Transplantation in Patients With High and Very High Risk Acute Leukemia/MyelodysplasiaStatus: Active (not recruiting), Estimated PCD: 2026-02-01
Clinical trial
A Phase II Open-label Study of ECT-001-expanded Cord Blood Transplantation in Patients With High-risk Acute Leukemia/MyelodysplasiaStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Product
ECT-001